U.S. Stem Cell Clinic: Stem Cell Banking The U.S. Stem Cell Clinic is founded on the principle belief that the quality of life for our patients can be improved through stem cell therapy. We are dedicated to providing safe and effective... By: U.S. Stem Cell Clinic … Continue reading →

U.S. Stem Cell Clinic: How long will my recovery take? Our U.S. Stem Cell Clinic procedure is minimally invasive and patients walk out within 3 hours in most cases. As a result recovery time is very quick. Many patients will experience soreness... By: U.S. Stem Cell Clinic … Continue reading →

U.S. Stem Cell Clinic: How is Stem Cell Therapy Performed? Our U.S. Stem Cell Clinic will perform outpatient procedures using a process in which we isolate a patient's own stem cells from either their own adipose fat tissue or bone marrow. Approximately... By: U.S. Stem Cell Clinic … Continue reading →

U.S. Stem Cell Clinic: What is Stem Cell Therapy? What is Stem Cell Therapy? Stem cell therapy attempts to harness the body's own healing potential by isolating stem cells from one location of the body (fat tissue or bone marrow) and relocating... By: U.S. Stem Cell Clinic … Continue reading →

U.S. Stem Cell Clinic: When should I expect to see results? It is important to note that we are treating patients with their own adult stem cells, therefore each treatment and response is unique to that patient. No guarantee can be made of what results... By: U.S. Stem Cell Clinic … Continue reading →

Using induced pluripotent stem cells (iPSCs), a team led by Mount Sinai researchers has gained new insight into genetic changes that may turn a well known anti-cancer signaling gene into a driver of risk for bone cancers, where the survival rate has not improved in 40 years despite treatment advances. The study results, published today in the journal Cell, revolve around iPSCs, which since their 2006 discovery have enabled researchers to coax mature (fully differentiated) bodily cells (e.g. skin cells) to become like embryonic stem cells. Such cells are pluripotent, able to become many cell types as they multiply and differentiate to form tissues. The iPSCs can then be converted again as needed into differentiated cells such as heart muscle, nerve cells, bone, etc. While some seek to use iPSCs as replacements for cells compromised by disease, the new Mount Sinai study sought to determine if they could serve as an accurate model of genetic disease "in a dish." In this context, the dish stands for a self-renewing, unlimited supply of iPSCs or a cell line - which enables in-depth study of disease versions driven by each person's genetic differences. When matched with patient records, iPSCs and iPSC-derived target cells … Continue reading →

Parkinson's is an incurable progressive condition of the brain. It affects movement, speech and balance and causes incessant shivering of the face and limbs. Genetic and environmental factors are believed to contribute to the degeneration of brain cells that maintain bodily movement. There is no particular test to detect the disease, with only physical symptoms enabling doctors to make a diagnosis. After 15 years of suffering and two failed stem cell transplantation surgeries, a 68-year-old businessman finally decided to undergo surgery on the eve of World Parkinson's Day at Jaslok Hospital. According to the doctors, the businessman, who is from Gujarat, had uncontrolled Parkinson's disease (PD) and was lured by the temptation of finding a 'cure' for the disease. "He was lured by the temptation of finding a 'cure' for Parkinson's disease he underwent intracranial stem cell transplantation (a neurosurgical procedure) in Bangalore. As he did not obtain any benefit, he was given a 'top up' by the intravenous stem cell route. Obviously, none of these worked and his disease progressed," said Dr Paresh Doshi, Director, Neurosurgery Department at Jaslok Hospital. As the disease progressed, Jain decided to go for deep brain stimulation (DBS) surgery, a standard surgical treatment for … Continue reading →

Apr 10, 2015 by Stephanie Dutchen New research indicates how and when adult intestinal stem cells (dark pink) set up shop at the base of villi, as shown in this image from the intestine of a chick near hatching. Credit: Tabin lab Mommy, where do intestinal stem cells come from? All right, it's not likely a kindergartner would ask such a question. But evolutionary biologists want to know. Adult intestinal stem cells live at the bases of our villi, the tiny, fingerlike protuberances that line the intestines and absorb nutrients. There, the stem cells constantly churn out new intestinal cells to replace those being destroyed by corrosive digestive juices. The researchers asked: How and when do these stem cells appear in the right place so they can do their job? Studying mice and chicks, whose intestinal formation is similar to ours, the team found that the entire intestinal lining has stem cell properties at first. As the embryo develops, all but a few cells lose this potential. "This lends support to the theory that adult stem cells are remnants of a more general pool of cells in the embryo," said Amy Shyer, who conducted the work as a graduate student … Continue reading →